Srinivas Rao

Srinivas G.
Rao was the founder of Kyalin Biosciences, Inc. founded in 2011, serving as Chief Executive Officer from 2011 to 2013.
Dr. Rao is the founder of ATAI Life Sciences AG founded in 2018, serving as Chief Scientific Officer since 2018.
Dr. Rao is the founder of Kures, Inc. founded in 2019, serving as Chief Scientific Officer since 2022.
Dr. Rao was the founder of Atai Beckley NV founded in 2018, serving as Co-Chief Executive Officer in 2024.
Dr. Rao is also the founder of IntroSpect Digital Therapeutics, Inc...
Dr. Rao is Chief Executive Officer at EntheogeniX Biosciences, Inc. since 2019.
Dr. Rao is Chief Executive Officer & Director at Atai Beckley, Inc. starting 2025.
Dr. Rao is Director at Perception Neuroscience, Inc. Dr. Rao is Member of Society For Neuroscience.
Dr. Rao is Member of American College of Neuropsychopharmacology.
Former positions include Chief Scientific Officer & Director-Science at Cypress Bioscience, Inc. from 2000 to 2009.
Non-Executive Director at Bionomics Ltd. from 2020 to 2021.
Director at IntelGenx Technologies Corp.
from 2021 to 2023.
Director at AVACEN, Inc. Chief Medical Officer & Senior Vice President at Assertio Therapeutics, Inc. from 2014 to 2017.
Member of American Pain Society.
Member of International Association for the Study of Pain.
Chief Scientific Officer at Sova Pharmaceuticals, Inc. Executive VP & Head-Neuroscience Division at Travere Therapeutics, Inc. from 2013 to 2014.
Chief Medical Officer at Vertero Therapeutics, Inc. from 2017 to 2019.
Chief Medical Officer at GABA Therapeutics, Inc. Education includes doctorate degrees from Yale School of Medicine and Yale Graduate School of Arts & Sciences.